1. Home
  2. DCGO vs LTRN Comparison

DCGO vs LTRN Comparison

Compare DCGO & LTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DocGo Inc.

DCGO

DocGo Inc.

HOLD

Current Price

$0.60

Market Cap

51.7M

Sector

Health Care

ML Signal

HOLD

Logo Lantern Pharma Inc.

LTRN

Lantern Pharma Inc.

HOLD

Current Price

$3.60

Market Cap

46.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DCGO
LTRN
Founded
2015
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Managed Health Care
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
51.7M
46.8M
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
DCGO
LTRN
Price
$0.60
$3.60
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$2.38
N/A
AVG Volume (30 Days)
1.3M
183.8K
Earning Date
05-11-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
18.65
EPS
N/A
N/A
Revenue
$322,196,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$6.77
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.45
$1.11
52 Week High
$1.78
$5.74

Technical Indicators

Market Signals
Indicator
DCGO
LTRN
Relative Strength Index (RSI) 57.74 50.22
Support Level $0.47 $3.09
Resistance Level $0.65 $3.79
Average True Range (ATR) 0.05 0.35
MACD 0.01 -0.10
Stochastic Oscillator 91.21 46.51

Price Performance

Historical Comparison
DCGO
LTRN

About DCGO DocGo Inc.

DocGo Inc is a provider of last-mile mobile health services and integrated medical mobility solutions. The company uses its care delivery platform to provide mobile health services, virtual care management, and ambulance services. It has two reporting segments: Mobile Health Services and Transportation Services. A majority of its revenue is generated from the Mobile Health Services segment, which includes various healthcare services performed at homes, offices, and other locations and event services such as on-site healthcare support at sporting events and concerts. Geographically, the company generates a majority of its revenue from the United States and the rest from the United Kingdom.

About LTRN Lantern Pharma Inc.

Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform. The company utilizes its proprietary RADR platform to identify, develop, and advance small molecule therapies and antibody-drug conjugates, with a pipeline that includes three lead small molecule drug candidates (LP-300, LP-184, and LP-284) targeting solid tumors and blood cancers. It also advances programs through its subsidiary focused on central nervous system and brain cancers.

Share on Social Networks: